Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Fidelio Capital AB in connection with its investment in Greenfood
Mandate

Vinge has advised Fidelio Capital AB in connection with its investment in Greenfood

August 11, 2025 M&A Employment and Benefits Trade Compliance Real Estate and Construction Commercial Agreements IT, Telecommunications and Outsourcing Financial Regulatory Intellectual Property EU, Competition and Regulatory Environmental Law Market surveillance

Vinge has advised Fidelio Capital AB in connection with its majority investment in Greenfood.

Fidelio, which has been a long-standing minority shareholder for almost 15 years is increasing its ownership in Greenfood by acquiring Nordic Capital’s stake in the group and becoming the majority owner of Greenfood.

Vinge’s team consisted of among others Jonas Bergström, Johanna Wiberg, Amanda Steen, Edvard Gustafson, Lovisa Jonassen and Anna Neubüser (M&A), Alice Göransson and Louisa Fagarasan (Employment), Hayaat Ibrahim (Compliance), Hanna Kövamees and Wilma Hellman (Real Estate), Mario Saad and Gabriel Pålsson (Commercial Agreements), Nicklas Thorgerzon, Filippa Eriksson and Sara Link (IT), Albert Wållgren, Felix Möller, Nour Makie and Gabriel Chabo (Financial Arrangements), Melinda Oldenburg, Maja Helm and Vilma Simonius (IP), Martin Johansson and Filippa Berggren (State Aid), Stina Larsson (Environment and Permits), Sebastian Örndahl, Noelia Martinez, Hilda Ivarson, Hampus Peterson and Lovisa Arpi (Merger Control) and Ellinore Boström Andersson (Transaction Support Coordinator).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026